ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Correction: Appropriations Reports Included Language of Minorities and Underserved

October 15, 1999

New Methods Uncover 1,800 RNAs Linked To Breast Cancer

December 30, 2011

Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center

March 5, 1999

New SEER RFP Sees cheaper Way To Get Data

July 29, 1977

Protocol Amendments Required For 98 NCI-Sponsored Trials

October 8, 2010

Final Issue of 1980

December 19, 1980